X
09Oct

Caremark Round II: Beware Red Flags in Drug Development

Goodwin | | Return|
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/caremark-round-ii-beware-red-flags-in-18599/

Related

IR35: case update

IR35 was introduced to crack down on perceived tax avoidance whereby individuals would seek to avoid...

Read More >

New Jersey Becomes the Latest State to Enact a Ban on Salary History Inquiries

On July 25, 2019, New Jersey became the latest state to join the movement banning salary history inq...

Read More >

Recent New York State Supreme Court Cases Impact RPAPL 881

As we advised in June 2019, there was an unprecedented decision by Justice Melissa Crane of the New ...

Read More >

Financial institutions M&A: Sector trends - July 2020: Payments

Financial Institutions M&A sector trends: Payments — H1 2020 and outlook for H2 2020. Lockdown uti...

Read More >

The message has to resonate

For some reason, my unincorporated village doesn’t have a mayor or village board of trustees, but w...

Read More >